We are live on ! Find out more

3,262 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 589 funds opening new positions, 1,254 increasing their positions, 1,155 reducing their positions, and 86 closing their positions.

New
Increased
Maintained
Reduced
Closed

585% more first-time investments, than exits

New positions opened: 589 | Existing positions closed: 86

136% more funds holding in top 10

Funds holding in top 10: 106250 (+144)

39% more capital invested

Capital invested by funds: $160B → $222B (+$62.1B)

16% more funds holding

Funds holding: 2,8033,262 (+459)

9% more repeat investments, than reductions

Existing positions increased: 1,254 | Existing positions reduced: 1,155

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.96% more ownership

Funds ownership: 66.41%67.38% (+0.96%)

Holders
3,262
Holders Change
+459
Holders Change %
+16.38%
% of All Funds
50.2%
Holding in Top 10
250
Holding in Top 10 Change
+144
Holding in Top 10 Change %
+135.85%
% of All Funds
3.85%
New
589
Increased
1,254
Reduced
1,155
Closed
86
Calls
$5.34B
Puts
$5.26B
Net Calls
+$77M
Net Calls Change
-$240M
Name Holding Trade Value Shares
Change
Change in
Stake
SAM
601
Sectoral Asset Management
Quebec, Canada
$12.3M +$4.34M +87,500 +72%
PSUF
602
People's United Financial
Connecticut
$12.3M -$1.32M -26,631 -11%
WSFS
603
Wilmington Savings Fund Society
Delaware
$12.2M -$151K -3,049 -1%
CCMD
604
Cypress Capital Management (Delaware)
Delaware
$12.2M +$446K +9,005 +5%
MCM
605
Maryland Capital Management
Maryland
$12.2M +$46.8K +944 +0.5%
TU
606
TDAM USA
Ontario, Canada
$12.2M -$10.1M -203,005 -50%
WS
607
Wedbush Securities
California
$12.2M +$270K +5,459 +3%
Rafferty Asset Management
608
Rafferty Asset Management
New York
$12.1M +$470K +9,494 +5%
ISB
609
Iowa State Bank
Iowa
$12.1M +$805K +16,254 +9%
SMFG
610
Sumitomo Mitsui Financial Group
Japan
$12M +$310K +6,249 +3%
RBA
611
Richard Bernstein Advisors
New York
$12M
PA
612
Profund Advisors
Maryland
$12M +$716K +14,459 +8%
WC
613
Whitney & Co
New York
$11.9M +$25.7K +518 +0.3%
FMC
614
First Merchants Corp
Indiana
$11.9M -$703K -14,190 -7%
Bessemer Group
615
Bessemer Group
New Jersey
$11.8M +$1.43M +28,928 +17%
MDCM
616
Morgan Dempsey Capital Management
Wisconsin
$11.8M -$380K -7,670 -4%
IHAM
617
Integral Health Asset Management
New York
$11.8M -$2.48M -50,000 -20%
KPWS
618
Kestra Private Wealth Services
Texas
$11.8M +$790K +15,946 +9%
AAA
619
Adams Asset Advisors
Texas
$11.7M -$2.87M -58,011 -23%
FFBTD
620
First Financial Bank - Trust Division
Ohio
$11.7M -$15.3K -308 -0.2%
Cerity Partners
621
Cerity Partners
New York
$11.7M +$2.19M +44,295 +27%
CIC
622
Carnegie Investment Counsel
Ohio
$11.7M +$216K +4,364 +2%
BWM
623
Buckley Wealth Management
Nevada
$11.7M -$492K -9,935 -5%
JIC
624
Johnson Investment Counsel
Ohio
$11.6M -$414K -8,348 -4%
GIM
625
Goelzer Investment Management
Indiana
$11.6M -$18K -364 -0.2%

PFE Hedge Fund Activity: Q4 2021 in Review

3,262 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2021, worth a combined $222B — up 39% from $160B a quarter earlier.

Buyers outnumbered sellers: 589 funds opened new PFE positions and 86 closed out — a net gain of 503 holders — while 1,254 added to existing stakes and 1,155 trimmed.

The largest buyer was DZ Bank, adding an estimated $519M. The largest seller was Boston Partners, cutting an estimated $433M.

  • 3,262 institutional investors held Pfizer (PFE) as of Q4 2021, up from 2,803 in Q3 2021.
  • Funds reported $222B of Pfizer stock for Q4 2021, up 39% quarter-over-quarter.
  • 589 funds opened new Pfizer positions in Q4 2021 and 86 closed out, a net change of +503 holders.
  • The largest Pfizer buyer in Q4 2021 was DZ Bank, an estimated $519M added.
  • The largest Pfizer seller in Q4 2021 was Boston Partners, an estimated $433M sold.

Based on aggregated 13F filings for Q4 2021.